Benzinga's Top #PreMarket Losers

Verastem Inc VSTM shares fell 53.97 percent to $2.61 in pre-market trading after the company reported stopping enrollment in COMMAND study of VS-6063. Exelixis, Inc. EXEL shares declined 4.91 percent to $5.62 in pre-market trading after falling 4.68 percent on Friday. Bellerophon Therapeutics Inc BLPH fell 4.76 percent to $6 in pre-market trading after jumping 69.35 percent on Friday. Vascular Biogenics Ltd VBLT shares tumbled 3.76 percent to $9.48 in pre-market trading after the company reported Phase 2 data from trial of VB-111 in rGBM at the ECC 2015 conference. Newmont Mining Corp NEM shares dipped 2.35 percent to $16.20 in pre-market trading after declining 1.07 percent on Friday.